Clinical trials
Terminated Multiple Myeloma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
484 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 4 |
| 2001 | 6 |
| 2002 | 7 |
| 2003 | 5 |
| 2004 | 13 |
| 2005 | 17 |
| 2006 | 19 |
| 2007 | 23 |
| 2008 | 33 |
| 2009 | 21 |
| 2010 | 26 |
| 2011 | 14 |
| 2012 | 25 |
| 2013 | 25 |
| 2014 | 26 |
| 2015 | 13 |
| 2016 | 24 |
| 2017 | 30 |
| 2018 | 30 |
| 2019 | 27 |
| 2020 | 28 |
| 2021 | 25 |
| 2022 | 17 |
| 2023 | 12 |
| 2024 | 3 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 484 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Masonic Cancer Center, University of Minnesota | 16 |
| National Cancer Institute (NCI) | 16 |
| Celgene | 14 |
| Washington University School of Medicine | 12 |
| M.D. Anderson Cancer Center | 11 |
| University of Arkansas | 10 |
| Amgen | 8 |
| Mayo Clinic | 8 |
| Novartis Pharmaceuticals | 8 |
| Barbara Ann Karmanos Cancer Institute | 7 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Myeloma | 484 |
| Neoplasms, Plasma Cell | 83 |
| Lymphoma | 78 |
| Lymphoma, Non-Hodgkin | 75 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 71 |
| Myelodysplastic Syndromes | 68 |
| Leukemia, Myeloid, Acute | 67 |
| Recurrence | 67 |
| Hodgkin Disease | 65 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 65 |
Trials
Showing 51 to 75 of 484. Each trial links to its page on Pharma Observatory.
384 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.